FDA Expands Xpert MTB/RIF Test Use The Food and Drug Administration (FDA) has granted clearance for the Cepheid Xpert MTB/RIF Assay to help determine if patients with suspected tuberculosis (TB) can ...
Evaluation of the Xpert MTB/RIF Test for the Diagnosis of Childhood Pulmonary Tuberculosis in Uganda
In the policy statement on the Xpert MTB/RIF test in 2011, the WHO recommended the use of the test as an initial diagnostic tool among children with suspected HIV associated TB or MDR TB based on ...
Built in a matter of months, Seek Labs’ functional investigational prototype delivers point-of-care Mycobacterium tuberculosis detection without instrumentation, electricity, or lab infrastructure.
Co-Diagnostics, Inc. , a molecular diagnostics company with a unique, proprietary platform for the development of molecular diagnostic tests, announced today that its Logix Smart™ MTB Test has ...
Cepheid ( CPHD) has entered into agreements with the Bill & Melinda Gates Foundation, the United States President's Emergency Plan for AIDS Relief (PEPFAR), the United States Agency for International ...
Evaluation of the Xpert MTB/RIF Test for the Diagnosis of Childhood Pulmonary Tuberculosis in Uganda
The study was approved by the School of Medicine Research and Ethics committee of Makerere University College of Health Sciences (# REC REF 2011–005). The children were enrolled upon provision of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results